Patent litigation attorney
Charles Klein
2 tracked appearances — 1 plaintiff · 1 defendant.
Specialty & background
The first result points to a senior "Chuck" Klein, but I need to verify whether he matches the tracked case data (Gibson Dunn + Crowell & Moring). Let me dig deeper.
The senior "Chuck Klein" is at Winston & Strawn, which doesn't match the tracked firms. Let me check his career history and also look for a separate Charles Klein connected to Gibson Dunn/Crowell & Moring.
Summary — Charles Klein (patent litigation)
Note on identity. The two tracked appearances in the case list (plaintiff side, of counsel, at Gibson Dunn & Crutcher; defendant side, counsel of record, at Crowell & Moring) do not match the only well-documented "Charles Klein" found in public sources: Charles B. "Chuck" Klein, a senior first-chair trial lawyer at Winston & Strawn in Washington, D.C. I found no reliable source linking that Winston & Strawn partner to Gibson Dunn or Crowell & Moring, so the tracked case data likely refers to a different attorney with the same name. The substance below therefore applies to the Winston & Strawn Charles B. Klein unless flagged otherwise; any profile of the tracked attorney should be verified against court dockets.
Specialty / focus and side. If the tracked attorney is Charles B. Klein, his practice is almost exclusively defendant-side work for operating companies in the pharmaceutical and biotechnology industries — Hatch-Waxman/ANDA disputes, BPCIA biosimilar litigation, and patent-antitrust matters, including billion-dollar cases (Chambers, IAM, Legal 500). That fits one side of the tracked data (defendant, counsel of record at Crowell & Moring), but the tracked data also shows one plaintiff-side matter at Gibson Dunn — a mix consistent with a practitioner who mostly defends drug manufacturers but can appear on the offensive side. I could not verify the technology areas of the specific tracked cases (e.g., whether they involve Wi-Fi/SEP, software, or pharma).
Firm context and notable outcomes (Charles B. Klein). He is the D.C. litigation office head at Winston & Strawn, a former co-chair of the firm's IP practice, and has litigated for roughly 30 years. Notable verifiable results include the U.S. Supreme Court's 9-0 affirmance in Caraco Pharmaceutical Laboratories v. Novo Nordisk (2012), a Hatch-Waxman counterclaim case, a defense jury verdict in a $1.7 billion pharmaceutical antitrust case, multiple Federal Circuit arguments, and lead-counsel roles in mRNA and BPCIA disputes. If the tracked attorney is a different Charles Klein, these results do not apply and his record is not publicly well sourced.
PTAB / IPR; bar / education. No public source indicates either Charles Klein appears regularly in IPR/PGR proceedings; the documented practice is district-court and Federal Circuit litigation. Charles B. Klein is admitted in Virginia (1995) and the District of Columbia (1996), with a B.A. from the University of Virginia (1992) and a J.D. from UC Hastings (1995) — credentials that should not be attributed to the tracked attorney until identity is confirmed.
Firms
Roles
- of counsel1
- counsel of record1
Cases (2)
- π plaintiffCase 18-2209 — U.S. Court of Appeals for the Federal CircuitGibson Dunn & Crutcher · of counsel
- Δ defendantCase 18-2209 — U.S. Court of Appeals for the Federal CircuitCrowell & Moring · counsel of record